Navigation Links
Genetic analysis reveals range of Rett syndrome
Date:3/11/2008

The first comprehensive analysis of the clinical effects of genetic mutations involved in Rett syndrome will enable affected families to receive a more accurate indication of their childs prognosis.

The research was undertaken by an international collaboration based on information provided by families and clinicians from around the world to the InterRett online database at the Telethon Institute for Child Health Research.

The results have just been published in the March edition of the prestigious international journal Neurology.

Report co-author, Dr Helen Leonard, who heads the Australian Rett Syndrome Study, said the findings have revealed a wide variability in the effects of the syndrome.

This is the first time that weve had quality information about a sufficient number of cases to be able to do a rigorous analysis comparing specific genetic mutations with they way the disorder is manifested in affected girls, Dr Leonard said.

While Rett syndrome is caused by a mutation on the MECP2 gene on the X chromosome, variations in the mutation determine the severity of symptoms.

Our analysis of eight common mutations that account for two-thirds of cases, showed considerable variation in abilities

Dr Leonard said the information would be of great value to families, clinicians and carers.

Many parents have found the lack of information about their daughters prognosis very distressing and will welcome a clearer indication of what they might expect in the future, Dr Leonard said.

Our findings really emphasised how much variability there is in the syndrome and we hope that information will assist with earlier diagnosis.

Dr Leonard said that girls with the milder form of Rett syndrome may retain some language, hand function and the ability to walk. In contrast, those with the severe form dont show the usual pattern of regression but are affected from birth.


'/>"/>

Contact: Liz Chester
elizabeth@ichr.uwa.edu.au
61-894-897-965
Research Australia
Source:Eurekalert

Page: 1

Related medicine news :

1. Genetic research unveils common origins for distinct clinical diagnoses
2. New stem cell technique improves genetic alteration
3. Einstein researchers genetically engineer immune cells into potent weapons for battling HIV
4. Genetic Test Predicts Response to Warfarin
5. New revelations in epigenetic control shed light on breast cancer
6. Researchers identify new genetic marker for breast cancer
7. Anti-Aging/Genetic Health Leader Suracell, Inc. Expands Internationally
8. Adult stem cell changes underlie rare genetic disease associated with accelerated aging
9. Genetic Factors for Smoking Boost Chronic Bronchitis Risk
10. Genetic factors in smoking also increase risk of chronic bronchitis
11. Dr. Robert Leonard First in New England to Offer Genetic Test for Male Pattern Baldness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a ... “The Journey: From the Mountains to the Mission Field” is the creation of published ... all ages and currently teaches a class of ladies at her church, which she ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and ... apnea using cutting-edge Oventus O2Vent technology. As many as 18 million Americans ... frequent cessation in breathing. Oral appliances can offer significant relief to about 75 ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ... today the introduction of an innovative new design of the shoulder pad. The ... get maximum comfort while controlling your pain while using cold therapy. By utilizing ice ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... D.C. (PRWEB) , ... October 12, 2017 , ... Leading ... their peers in Washington, D.C., for the 49th Congress of the International Society ... ., Vice President of the Center for Cancer and Blood Disorders at ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... West Pharmaceutical Services, Inc. (NYSE: ... drug administration, today announced that it will release third-quarter ... October 26, 2017, and will follow with a conference ... 9:00 a.m. Eastern Time. To participate on the call, ... ID is 94093362. ...
(Date:10/11/2017)... , Oct. 11, 2017  True Health, a ... amplified its effort during National Breast Cancer Awareness ... cancer risks. ... Oncology calculated that more than 10 million American ... mutations in BRCA1 or BRCA2 and have not had ...
(Date:10/10/2017)... 10, 2017   West Pharmaceutical Services, Inc. ... injectable drug administration, today shared the results of a ... improving the intradermal administration of polio vaccines. The study ... in May 2017 by Dr. Ondrej Mach , ... Health Organization (WHO), and recently published in the journal ...
Breaking Medicine Technology: